Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Targeted therapy for glioblastoma multiforme neoplastic meningitis with intrathecal delivery of an oncolytic recombinant poliovirus.

Publication ,  Journal Article
Ochiai, H; Campbell, SA; Archer, GE; Chewning, TA; Dragunsky, E; Ivanov, A; Gromeier, M; Sampson, JH
Published in: Clin Cancer Res
February 15, 2006

PURPOSE: The toxicity and antitumor activity of regional intrathecal delivery of an oncolytic recombinant poliovirus, PVS-RIPO, was evaluated in rodent models of glioblastoma multiforme neoplastic meningitis. EXPERIMENTAL DESIGN: To evaluate for toxicity, PVS-RIPO was administered into the spinal cord of transgenic mice that express the human poliovirus receptor, CD155, and into the intrathecal space of athymic rats without tumor. To evaluate efficacy, two different doses of PVS-RIPO were administered intrathecally 3 days after athymic rats were inoculated intrathecally with an aggressive human glioblastoma multiforme xenograft. RESULTS: No clinical or histologic evidence of toxicity was found. In efficacy studies, median survival was increased by 174.47% from 8.5 days in the group treated with UV light-inactivated virus to 15 days in the rats treated with 1.0 x 10(7) plaque-forming units (pfu) of PVS-RIPO (P < 0.0001). A similar increase in median survival was seen in the group receiving 1.0 x 10(9) pfu PVS-RIPO (P < 0.0001); however, there was no statistically significant dose-response relationship (P = 0.345). In addition, 1 of 10 rats in lower-dose PVS-RIPO-treated group and 3 of 10 rats in higher-dose PVS-RIPO-treated group survived >60 days after tumor cell inoculation and had no evidence of residual tumor at autopsy. CONCLUSION: These results suggest that intrathecal treatment with PVS-RIPO may be useful for treatment of neoplastic meningitis in patients with glioblastoma multiforme and provides a rationale for clinical trials in this area.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Clin Cancer Res

DOI

ISSN

1078-0432

Publication Date

February 15, 2006

Volume

12

Issue

4

Start / End Page

1349 / 1354

Location

United States

Related Subject Headings

  • Xenograft Model Antitumor Assays
  • Survival Analysis
  • Recombination, Genetic
  • Receptors, Virus
  • Rats, Nude
  • Rats
  • Poliovirus Vaccine, Inactivated
  • Poliovirus
  • Oncology & Carcinogenesis
  • Mice, Transgenic
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ochiai, H., Campbell, S. A., Archer, G. E., Chewning, T. A., Dragunsky, E., Ivanov, A., … Sampson, J. H. (2006). Targeted therapy for glioblastoma multiforme neoplastic meningitis with intrathecal delivery of an oncolytic recombinant poliovirus. Clin Cancer Res, 12(4), 1349–1354. https://doi.org/10.1158/1078-0432.CCR-05-1595
Ochiai, Hidenobu, Stephanie A. Campbell, Gary E. Archer, Tracy A. Chewning, Eugenia Dragunsky, Alexander Ivanov, Matthias Gromeier, and John H. Sampson. “Targeted therapy for glioblastoma multiforme neoplastic meningitis with intrathecal delivery of an oncolytic recombinant poliovirus.Clin Cancer Res 12, no. 4 (February 15, 2006): 1349–54. https://doi.org/10.1158/1078-0432.CCR-05-1595.
Ochiai H, Campbell SA, Archer GE, Chewning TA, Dragunsky E, Ivanov A, et al. Targeted therapy for glioblastoma multiforme neoplastic meningitis with intrathecal delivery of an oncolytic recombinant poliovirus. Clin Cancer Res. 2006 Feb 15;12(4):1349–54.
Ochiai, Hidenobu, et al. “Targeted therapy for glioblastoma multiforme neoplastic meningitis with intrathecal delivery of an oncolytic recombinant poliovirus.Clin Cancer Res, vol. 12, no. 4, Feb. 2006, pp. 1349–54. Pubmed, doi:10.1158/1078-0432.CCR-05-1595.
Ochiai H, Campbell SA, Archer GE, Chewning TA, Dragunsky E, Ivanov A, Gromeier M, Sampson JH. Targeted therapy for glioblastoma multiforme neoplastic meningitis with intrathecal delivery of an oncolytic recombinant poliovirus. Clin Cancer Res. 2006 Feb 15;12(4):1349–1354.

Published In

Clin Cancer Res

DOI

ISSN

1078-0432

Publication Date

February 15, 2006

Volume

12

Issue

4

Start / End Page

1349 / 1354

Location

United States

Related Subject Headings

  • Xenograft Model Antitumor Assays
  • Survival Analysis
  • Recombination, Genetic
  • Receptors, Virus
  • Rats, Nude
  • Rats
  • Poliovirus Vaccine, Inactivated
  • Poliovirus
  • Oncology & Carcinogenesis
  • Mice, Transgenic